Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach.

ABSTRACT: More than half of males in China are current smokers and evidence from western countries tells us that an unprecedented number of smoking-attributable deaths will occur as the Chinese population ages. We used the China Lung Cancer Policy Model (LCPM) to simulate effects of computed tomography (CT)-based lung cancer screening in China, comparing the impact of a screening guideline published in 2015 by a Chinese expert group to a version developed for the United States by the U.S. Centers for Medicare & Medicaid Services (CMS). The China LCPM, built using an existing lung cancer microsimulation model, can project population outcomes associated with interventions for smoking-related diseases. After calibrating the model to published Chinese smoking prevalence and lung cancer mortality rates,

SUBMITTER: Sheehan DF 

PROVIDER: S-EPMC5342219 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature